Based on a 1996 United States Department of Agriculture (USDA) survey of 1,178 dairy producers and a milk price of $13 per hundredweight (cwt), optimal recombinant bovine somatotropin (rBST) use would be 73 percent of cows. Such a rate would increase herdlevel milk production by 2,983 pounds per cow and herd-level net returns by $126 per cow.Includes bibliographical reference
whether recombinant bovine Somatotropin (rbST) generated profits for adopters. Results show that the...
Since its adoption in 1994 in the United States (U.S.), Monsanto's rBST product, Posilac, has been v...
This study evaluated the impacts of bST on the profitability of representative Pennsylvania dairy fa...
Based on a 1996 United States Department of Agriculture (USDA) survey of 1,178 dairy producers and a...
New York dairy farm data over the years 1994-2002 were used to estimate the impact of recombinant bo...
Data from New York dairy farms for the years 1994 through 1997 were used to estimate whether recombi...
Production and financial impacts of recombinant bovine somatotropin (rbST) adoption are assessed usi...
Production and financial impacts of recombinant bovine somatotropin (rbST) adoption are assessed usi...
The production and profit impacts of recombinant Bovine Somatotropin (rbST) on select New York dairy...
This study evaluated the impacts of bST on the profitability of representative Pennsylvania dairy fa...
Production and profit impacts from the use of recombinant Bovine Somatotropin (rbST) on dairy farms ...
The potential economic impacts of the introduction of bovine somatotropin (bST) on U.S. milk supply ...
Bovine somatoropin (bST) alters total milk production and production patterns in dairy cows and unde...
Production and profit impacts from the use of recombinant Bovine Somatotropin (rbST) on dairy farms ...
The empirical impact of rBST was measured for 211 dairy farms using 1993-95 data. Farms applying rB...
whether recombinant bovine Somatotropin (rbST) generated profits for adopters. Results show that the...
Since its adoption in 1994 in the United States (U.S.), Monsanto's rBST product, Posilac, has been v...
This study evaluated the impacts of bST on the profitability of representative Pennsylvania dairy fa...
Based on a 1996 United States Department of Agriculture (USDA) survey of 1,178 dairy producers and a...
New York dairy farm data over the years 1994-2002 were used to estimate the impact of recombinant bo...
Data from New York dairy farms for the years 1994 through 1997 were used to estimate whether recombi...
Production and financial impacts of recombinant bovine somatotropin (rbST) adoption are assessed usi...
Production and financial impacts of recombinant bovine somatotropin (rbST) adoption are assessed usi...
The production and profit impacts of recombinant Bovine Somatotropin (rbST) on select New York dairy...
This study evaluated the impacts of bST on the profitability of representative Pennsylvania dairy fa...
Production and profit impacts from the use of recombinant Bovine Somatotropin (rbST) on dairy farms ...
The potential economic impacts of the introduction of bovine somatotropin (bST) on U.S. milk supply ...
Bovine somatoropin (bST) alters total milk production and production patterns in dairy cows and unde...
Production and profit impacts from the use of recombinant Bovine Somatotropin (rbST) on dairy farms ...
The empirical impact of rBST was measured for 211 dairy farms using 1993-95 data. Farms applying rB...
whether recombinant bovine Somatotropin (rbST) generated profits for adopters. Results show that the...
Since its adoption in 1994 in the United States (U.S.), Monsanto's rBST product, Posilac, has been v...
This study evaluated the impacts of bST on the profitability of representative Pennsylvania dairy fa...